B16 melanoma cells are poorly immunogenic due to downregulation of transporters associated with antigen processing (TAP-1 and TAP-2) [33], resulting in reduced MHC class I expression and a diminished ability to present antigens to CD8+ T cells. Here, CD8A is linked to melanoma.